Conti, G.; D’Amico, F.; Fabbrini, M.; Brigidi, P.; Barone, M.; Turroni, S.
Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out. Genes 2023, 14, 55.
https://doi.org/10.3390/genes14010055
AMA Style
Conti G, D’Amico F, Fabbrini M, Brigidi P, Barone M, Turroni S.
Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out. Genes. 2023; 14(1):55.
https://doi.org/10.3390/genes14010055
Chicago/Turabian Style
Conti, Gabriele, Federica D’Amico, Marco Fabbrini, Patrizia Brigidi, Monica Barone, and Silvia Turroni.
2023. "Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out" Genes 14, no. 1: 55.
https://doi.org/10.3390/genes14010055
APA Style
Conti, G., D’Amico, F., Fabbrini, M., Brigidi, P., Barone, M., & Turroni, S.
(2023). Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out. Genes, 14(1), 55.
https://doi.org/10.3390/genes14010055